Effect of amyloid, tau and syndromic stages of Alzheimer's disease (AD) in speech markers: A potential scalable tool for screening in AD clinical trials

Abstract

Background: Speech and language changes occur decades before the clinical diagnosis of Alzheimer's disease (AD). Digital tools for frequent speech assessments may have promise for early‐stage AD trials.